"I am very pleased to announce these two well-deserved promotions on
"Gil has demonstrated exceptional business acumen and strong leadership skills during his tenure at
Over the tenure of his career,
In his new role as Senior Vice President & Chief Financial Officer,
About
MOVANTIK™ is a trademark and MOVENTIG® is a registered trademark of the AstraZeneca group of companies.
ADYNOVATE™ is a trademark of Baxalta Inc.
ONZEALD™ is a trademark of
Media Contacts:
415-482-5585
301-801-5540
rachel@purecommunicationsinc.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nektar-therapeutics-announces-executive-management-promotions-300279029.html
SOURCE
News Provided by Acquire Media